Skip to main content
QUCY
NASDAQ Life Sciences

Policy-Making Officer Files Intent to Sell $692K in Shares Amidst Company Pivot

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
9
Price
$3.394
Mkt Cap
$41.301M
52W Low
$0.3
52W High
$4.93
Market data snapshot near publication time

summarizeSummary

A policy-making officer of Quantum Cyber N.V. has filed a Form 144 to sell 200,000 shares valued at $692,000, shortly after receiving them as compensation, amidst the company's critical business pivot and financial challenges.


check_boxKey Events

  • Officer Files Intent to Sell Shares

    BAECHLER GUIDO, a policy-making officer, filed a Form 144 indicating intent to sell 200,000 common shares, valued at approximately $692,000.

  • Significant Stake Reduction

    The proposed sale represents about 1.675% of the company's current market capitalization, indicating a substantial disposition by a key executive.

  • Recent Compensation Liquidation

    The shares intended for sale were acquired as a stock award on April 22, 2026, meaning the officer is moving to sell them shortly after receiving them as compensation.

  • Context of Company Transition

    This intent to sell occurs as Quantum Cyber N.V. is undergoing a major business pivot to cyber/drones, has reported "going concern" doubts, and recently increased its At-The-Market (ATM) equity offering to $100 million.


auto_awesomeAnalysis

A policy-making officer's intent to sell $692,000 worth of shares, representing 1.675% of the company, is a significant negative signal. This comes shortly after the officer received these shares as a stock award on April 22, 2026. The sale occurs during a critical period for Quantum Cyber N.V., which is undergoing a radical business pivot from life sciences to cyber/drones, facing "going concern" doubts, and has recently expanded a highly dilutive At-The-Market (ATM) offering to $100 million. This executive's decision to liquidate a substantial portion of recently acquired compensation suggests a lack of confidence or an urgent need for liquidity amidst the company's turbulent transition.

At the time of this filing, QUCY was trading at $3.39 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $41.3M. The 52-week trading range was $0.30 to $4.93. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed QUCY - Latest Insights

QUCY
May 22, 2026, 12:32 PM EDT
Filing Type: 144
Importance Score:
10
QUCY
May 18, 2026, 4:28 PM EDT
Filing Type: 144
Importance Score:
9
QUCY
May 18, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
QUCY
May 15, 2026, 4:23 PM EDT
Source: Wiseek News
Importance Score:
9
QUCY
May 15, 2026, 4:09 PM EDT
Filing Type: 10-Q
Importance Score:
10
QUCY
May 13, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
QUCY
May 08, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
9
QUCY
May 08, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
QUCY
Apr 28, 2026, 5:29 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
QUCY
Apr 28, 2026, 5:03 PM EDT
Source: Wiseek News
Importance Score:
9